Journal: Influenza and Other Respiratory Viruses

Article Title: Viral co‐infections are associated with increased rates of hospitalization in those with influenza

doi: 10.1111/irv.12967

Figure Lengend Snippet: Summary of ePlex results by site (N = 999)

Article Snippet: Further characterization by Genmark ePlex testing of influenza subtypes and presence of viral co‐infections for the 999 specimens available for detailed characterization is described in Table .

Techniques: Virus

Journal: Influenza and Other Respiratory Viruses

Article Title: Viral co‐infections are associated with increased rates of hospitalization in those with influenza

doi: 10.1111/irv.12967

Figure Lengend Snippet: Patient characteristics by type of influenza co‐infection as determined by ePlex (N = 999)

Article Snippet: Further characterization by Genmark ePlex testing of influenza subtypes and presence of viral co‐infections for the 999 specimens available for detailed characterization is described in Table .

Techniques: Virus

Journal: Journal of Fungi

Article Title: An Overview on Candida auris in Healthcare Settings

doi: 10.3390/jof9090913

Figure Lengend Snippet: Summary of CDC algorithm ([ 32 ], modified).

Article Snippet: GenMark ePlex BCID-FP Panel , , Yes , n/a.

Techniques: Modification, Software

Journal: Frontiers in Medicine

Article Title: Rapid Antimicrobial Susceptibility Testing Methods for Blood Cultures and Their Clinical Impact

doi: 10.3389/fmed.2021.635831

Figure Lengend Snippet: Select genotypic tests that are approved for rapid detection of resistance markers in positive blood cultures.

Article Snippet: ePlex ® BCID-GN (GenMark) , 21 Gram-negative targets “pan” Gram-positive target “pan” Candida target , Carbapenemases bla IMP bla KPC bla OXA −48/ OXA −23 bla NDM bla VIM ESBL bla CTX − M , ( ) .

Techniques: Bla VIM Assay, Luminex

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT)

doi: 10.1128/AAC.00441-21

Figure Lengend Snippet: Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of ePlex BCID panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).

Article Snippet: Although the GenMark ePlex BCID demonstrated statistically higher mean DOOR-MAT scores than Verigene BC, both the immediate impact on an individual patient’s clinical outcome and the long-term impact on antimicrobial resistance is unknown.

Techniques:

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT)

doi: 10.1128/AAC.00441-21

Figure Lengend Snippet: Comparison of RDT platforms

Article Snippet: Although the GenMark ePlex BCID demonstrated statistically higher mean DOOR-MAT scores than Verigene BC, both the immediate impact on an individual patient’s clinical outcome and the long-term impact on antimicrobial resistance is unknown.

Techniques: